Abstract:Abstract The development of efficient aggregation‐induced emission (AIE) active probes is crucial for disease diagnosis, particularly for tumors and cardiovascular diseases. Current AIE‐active probes primarily focus on improving their water solubility to resist aggregation, thereby achieving an initial fluorescence‐off state. However, the complex biological environment can cause undesirable aggregation, resulting in false signals. To address this issue, we have ingeniously introduced an azo group into the AIE luminogen (AIEgen), developing a reductase‐activated AIE probe, Azo‐quinoline‐malononitrile (QM)‐PN, for imaging hypoxic environments. In this probe, the azo group promotes intramolecular motion through rapid E / Z isomerization, causing the excited state energy to dissipate via non‐radiative decay, thus turning off the initial fluorescence. In the presence of reductase, Azo‐QM‐PN is reduced and cleaved to produce the hydrophobic AIEgen NH 2 ‐QM‐PN, which subsequently aggregates and generates an in situ AIE signal, thereby imaging the hypoxic environment with reductase. Encapsulation of Azo‐QM‐PN with DSPE‐PEG 2000 results in the formation of the nanoprobe Azo‐QM‐PN NPs, which can effectively penetrate cell membranes, specifically illuminate tumor cells, monitor fluctuations in azo reductase levels, and deeply penetrate and image multicellular tumor spheroids, demonstrating potential for hypoxic tumor imaging. Additionally, the nanoprobe Azo‐QM‐PN NPs can selectively image hypoxic atherosclerotic plaque tissues, showing potential for detecting atherosclerosis. Therefore, in this study, we successfully developed an enzyme‐activated AIE probe for imaging hypoxic environments, laying the foundation for further clinical applications.

An activatable azophenyl fluorescent probe for hypoxic fluorescence imaging in living cells

Hypoxia-Responsive Molecular Probe Lighted up by Peptide Self-Assembly for Cancer Cell Imaging

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

An azo substituted quinoline‐malononitrile enzyme‐activable aggregation‐induced emission nanoprobe for hypoxia imaging

Supramolecular fluorescence nanoprobe loaded with azobenzene for the detection of azoreductase: Selective light-up of hypoxic cells

Fluorescent Probe for Hypoxia-triggered Imaging and Cancer Therapy

Application of Azobenzene Derivative Probes in Hypoxia Cell Imaging

Activatable Fluorescent Probe Based on Aggregation-Induced Emission for Detecting Hypoxia-Related Pathological Conditions.

"Turn-On" Activatable AIE Dots for Tumor Hypoxia Imaging.

A fluorescent turn-on probe for visualizing lysosomes in hypoxic tumor cells.

A Turn-On Fluorescent Probe for Tumor Hypoxia Imaging in Living Cells

Near-Infrared Fluorescent Probes for Hypoxia Detection via Joint Regulated Enzymes: Design, Synthesis, and Application in Living Cells and Mice.

<i>In situ</i> construction of a self-assembled AIE probe for tumor hypoxia imaging

Azo-based near-infrared fluorescent theranostic probe for tracking hypoxia-activated cancer chemotherapy in vivo.

Hypoxia-Activated Fluorescent Probe Based on Self-Immolative Block Copolymer

Selective Turn-on Near-Infrared Fluorescence Probe for Hypoxic Tumor Cell Imaging

A ZIF-90 Nanoplatform Loaded with an Enzyme-Responsive Organic Small-Molecule Probe for Imaging the Hypoxia Status of Tumor Cells.

A fluorescent probe for ultrarapid H2O2 detection during reagent-stimulated oxidative stress in cells and zebrafish

A two-photon mitochondria-targeting azo reductase probe for imaging in tumor cells and mice

Development of Azo‐Based Fluorescent Probes to Detect Different Levels of Hypoxia

Highly Selective Imaging of Lysosomal Azoreductase under Hypoxia Using Ph-Regulated and Target-Activated Fluorescent Nanoprobes